# Glaxo Operations U.K. Ltd., Barnard Castle, United Kingdom – FDA Inspections

Source: https://www.keypedia.com/companies/glaxo-operations-uk-ltd/5c8a39c9-a63a-4574-885a-c16948f20589

> Inspection records and compliance data for Glaxo Operations U.K. Ltd. in Barnard Castle. 11 FDA inspections on record, 4 Form 483s, last inspected March 16, 2023.

---

## Details

- Name: Glaxo Operations U.K. Ltd.
- FEI Number: 3002807078
- Address Line 1: Harmire Road
- City: Barnard Castle
- Country Name: United Kingdom
- Address: Harmire Road, Barnard Castle, United Kingdom
- Country: United Kingdom

## Related Documents

- [FDA Inspection 1211398 - Glaxo Operations U.K. Ltd. - 2023-03-16](https://www.keypedia.com/records/fda_inspections/glaxo-operations-uk-ltd/beeed03d-92cd-4f68-97d4-c6f9a9109c7f) — source: FDA, date: March 16, 2023
- FDA Inspection 1209851 - Glaxo Operations U.K. Ltd. - 2023-02-10 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 10, 2023
- [FDA Inspection 1107134 - Glaxo Operations U.K. Ltd. - 2019-09-17](https://www.keypedia.com/records/fda_inspections/glaxo-operations-uk-ltd/8391bdd5-8330-4bf7-97ff-df96b7424ec8) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 17, 2019
- [FDA Inspection 1016930 - Glaxo Operations U.K. Ltd. - 2017-07-04](https://www.keypedia.com/records/fda_inspections/glaxo-operations-uk-ltd/6a8728a5-569f-4a0c-b014-af35693fbfc0) — source: FDA, date: July 4, 2017
- [FDA Inspection 1014765 - Glaxo Operations U.K. Ltd. - 2017-06-02](https://www.keypedia.com/records/fda_inspections/glaxo-operations-uk-ltd/650fa308-f844-4b69-aa5d-3e08cca79293) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 2, 2017
- FDA Inspection 933676 - Glaxo Operations U.K. Ltd. - 2015-06-23 — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 23, 2015
- FDA Inspection 831335 - Glaxo Operations U.K. Ltd. - 2013-05-09 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 9, 2013
- FDA Inspection 746871 - Glaxo Operations U.K. Ltd. - 2011-09-22 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 22, 2011
- FDA Inspection 698025 - Glaxo Operations U.K. Ltd. - 2010-11-01 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 1, 2010
- FDA Inspection 597648 - Glaxo Operations U.K. Ltd. - 2009-05-22 — classification: No Action Indicated (NAI), source: FDA, date: May 22, 2009

## Related Companies

- [TevaRuncorn](https://www.keypedia.com/companies/tevaruncorn/275f62ca-3a9a-42c5-833e-0b8bd9c77831)
- [Baxter Heathcare Ltd](https://www.keypedia.com/companies/baxter-heathcare-ltd/8408dc3d-292e-4756-bb66-f6889bba6d48)
- [Cenexi Laboratoires Thissen SA](https://www.keypedia.com/companies/cenexi-laboratoires-thissen-sa/83fd3547-ba88-47a3-bc18-1658ed5b3c05)
- [Mitim SRL](https://www.keypedia.com/companies/mitim-srl/d806bfd1-0e19-4340-96f6-af9410b63284)
- [Merck Sante s.a.s](https://www.keypedia.com/companies/merck-sante-sas/71d1631f-93a6-4a97-b401-d18d7de86fc1)
- [Infomed Fluids SRL](https://www.keypedia.com/companies/infomed-fluids-srl/54e3928e-73bb-4780-98fa-5f3a69507315)
- [Cenexi HSC](https://www.keypedia.com/companies/cenexi-hsc/8faec806-3eb8-41af-9e39-b4a4269f602e)
- [Bieffe Medital, S.A.](https://www.keypedia.com/companies/bieffe-medital-sa/28a9d62d-50cd-4f2b-b89b-411f3d71b722)
- [Fareva Pau](https://www.keypedia.com/companies/fareva-pau/410f25e1-0b2b-4465-923c-a1a053a0a35d)
- [Solupharm Pharmazeutische Erzeugnisse Gmbh](https://www.keypedia.com/companies/solupharm-pharmazeutische-erzeugnisse-gmbh/dd3d4b95-d76b-4afa-b430-f1dee1ebb184)